Cystaran 01
The text is not-available.*
Cystaran Solution
Product Images NDC 54482-035
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cystaran (NDC 54482-035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Leadiant Biosciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Cystaran 02
Leadiant Biosciences is a company that focuses on developing and commercializing therapies for rare diseases.*
Cystaran 03
Cystaran is a topical ophthalmic solution used to treat corneal cystine crystal deposits in patients with cystinosis. Each milliliter of Cystaran contains 6.5mg cysteamine hydrochloride, equivalent to 4.4mg cysteamine, along with inactive ingredients such as benzalkonium chloride and sodium chloride. It should be stored in a freezer and thawed for about 24 hours before use, and discarded after a week of use. It is distributed by Leadiant Biosciences and made in Switzerland. Dosage information is not available.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
